Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabela Díaz de Corcuera

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 23, 2012
SEOM guidelines for endometrial cancerAna Oaknin, Víctor Rodríguez-Freixinós, Isabela Díaz de Corcuera, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 23, 2012
SEOM guidelines for cervical cancerAna Oaknin, Isabela Díaz de Corcuera, Víctor Rodríguez-Freixinós, et al.
Case Reports in Medicine|February 20, 2010
Ovarian Fibrosarcoma: Clinicopathologic Considerations about the Intraoperative and Post-Surgical ProceduresAngel García Jiménez, Josep Castellví, Assumpció Pérez Benavente, et al.
Expert Opinion on Drug Safety|June 17, 2015
Aflibercept for metastatic colorectal cancer: safety data from the Spanish named patient programMercedes Salgado Fernández, Maria Teresa Pérez Hoyos, Isabela Díaz de Corcuera, et al.
Cancers|January 11, 2024
Baseline Circulating Blood Cell Counts and Ratios and Changes Therein for Predicting Immune-Related Adverse Events during Immune Checkpoint Inhibitor Therapy: A Multicenter, Prospective, Observational, Pan-Cancer Cohort Study with a Gender PerspectiveLucía Teijeira, Mireia Martínez, Amaia Moreno, et al.
JAMA Network Open|April 22, 2024
Prevalence of Homologous Recombination Deficiency Among Patients With Germline RAD51C/D Breast or Ovarian CancerSara Torres-Esquius, Alba Llop-Guevara, Sara Gutiérrez-Enríquez, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 23, 2012
SEOM guidelines for endometrial cancerAna Oaknin, Víctor Rodríguez-Freixinós, Isabela Díaz de Corcuera, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 23, 2012
SEOM guidelines for cervical cancerAna Oaknin, Isabela Díaz de Corcuera, Víctor Rodríguez-Freixinós, et al.
Case Reports in Medicine|February 20, 2010
Ovarian Fibrosarcoma: Clinicopathologic Considerations about the Intraoperative and Post-Surgical ProceduresAngel García Jiménez, Josep Castellví, Assumpció Pérez Benavente, et al.
Expert Opinion on Drug Safety|June 17, 2015
Aflibercept for metastatic colorectal cancer: safety data from the Spanish named patient programMercedes Salgado Fernández, Maria Teresa Pérez Hoyos, Isabela Díaz de Corcuera, et al.
Cancers|January 11, 2024
Baseline Circulating Blood Cell Counts and Ratios and Changes Therein for Predicting Immune-Related Adverse Events during Immune Checkpoint Inhibitor Therapy: A Multicenter, Prospective, Observational, Pan-Cancer Cohort Study with a Gender PerspectiveLucía Teijeira, Mireia Martínez, Amaia Moreno, et al.
JAMA Network Open|April 22, 2024
Prevalence of Homologous Recombination Deficiency Among Patients With Germline RAD51C/D Breast or Ovarian CancerSara Torres-Esquius, Alba Llop-Guevara, Sara Gutiérrez-Enríquez, et al.
Pageof 1